Predictors of treatment failure on second-line antiretroviral therapy among adults in northwest Ethiopia: a multicentre retrospective follow-up study

Autor: Wubshet M, Addis Alene K, Tadesse Awoke, Adino Tesfahun Tsegaye

Publikováno v: BMJ Open

Background The number of patients using second-line antiretroviral therapy (ART) has increased over time. In Ethiopia, 1.5% of HIV infected patients on ART are using a second-line regimen and little is known about its effect in this setting. Objectiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f3f70ce91603f52034eb865916ef2c0
https://doi.org/10.1136/bmjopen-2016-012537

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Schistosomiasis in the People's Republic of China - down but not out.

Autor: Gordon CA; Department of Immunology, Molecular Parasitology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Williams GM; School of Population Health, Discipline of Epidemiology and Biostatistics, University of Queensland, Brisbane, Australia., Gray DJ; Department of Global Health, Research School of Population Health, Australian National University, Canberra, Australia., Clements ACA; Faculty of Health Sciences, Curtin University, Perth, Australia., Zhou XN; National Institute of Parasitic Diseases, Shanghai, People's Republic of China., Li Y; Department of Immunology, Molecular Parasitology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Hunan Institute of Schistosomiasis Control, Yueyang, Hunan, People's Republic of China., Utzinger J; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Kurscheid J; Department of Global Health, Research School of Population Health, Australian National University, Canberra, Australia.; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Forsyth S; School of Population Health, Discipline of Epidemiology and Biostatistics, University of Queensland, Brisbane, Australia., Addis Alene K; Faculty of Health Sciences, Curtin University, Perth, Australia., Zhou J; Hunan Institute of Schistosomiasis Control, Yueyang, Hunan, People's Republic of China., Li Z; Jiangxi Institute of Parasitic Diseases, Jiangxi, People's Republic of China., Li G; Hunan Institute of Schistosomiasis Control, Yueyang, Hunan, People's Republic of China., Lin D; Jiangxi Institute of Parasitic Diseases, Jiangxi, People's Republic of China., Lou Z; Hunan Institute of Schistosomiasis Control, Yueyang, Hunan, People's Republic of China., Li S; Hunan Institute of Schistosomiasis Control, Yueyang, Hunan, People's Republic of China., Ge J; Jiangxi Institute of Parasitic Diseases, Jiangxi, People's Republic of China., Xu J; National Institute of Parasitic Diseases, Shanghai, People's Republic of China., Yu X; Hunan Institute of Schistosomiasis Control, Yueyang, Hunan, People's Republic of China., Hu F; Jiangxi Institute of Parasitic Diseases, Jiangxi, People's Republic of China., Xie S; Jiangxi Institute of Parasitic Diseases, Jiangxi, People's Republic of China., Chen J; Chinese National Human Genome Center, Shanghai, People's Republic of China., Shi T; Chinese National Human Genome Center, Shanghai, People's Republic of China., Li C; Chinese National Human Genome Center, Shanghai, People's Republic of China., Zheng H; Chinese National Human Genome Center, Shanghai, People's Republic of China., McManus DP; Department of Immunology, Molecular Parasitology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.

Publikováno v: Parasitology [Parasitology] 2022 Feb; Vol. 149 (2), pp. 218-233. Date of Electronic Publication: 2021 Nov 03.